Dose‐level response rates of mtor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|10|1754-1760

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.10, 2015-10, pp. : 1754-1760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 616-621

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neonatal Subependymal Giant Cell Astrocytoma

By  

Pediatric Neurosurgery, Vol. 36, Iss. 5, 2002-05 ,pp. : 271-274

Karger

Access to resources Recommend Favorite

Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 929-938

John Wiley & Sons Inc

Access to resources Recommend Favorite

P10.08: Intracranial mass: have you checked the heart? SEGA as initial presentation of tuberous sclerosis complex in the fetus

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 196-197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thyroid transcription factor‐1 and epithelial membrane antigen expression in four cases of subependymal giant cell astrocytoma

By  

HISTOPATHOLOGY, Vol. 66, Iss. 7, 2015-06 ,pp. : 1035-1036

John Wiley & Sons Inc

Access to resources Recommend Favorite